Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study - Supplement
-
- Amy Ellinwood
- 寄与者
-
- Ko, Justin
- 寄与者
-
- Forman, Seth
- 寄与者
-
- Ohyama, Manabu
- 寄与者
-
- Yu, Guanglei
- 寄与者
-
- McCollam, Jill
- 寄与者
-
- Gamalo, Margaret
- 寄与者
-
- Janes, Jonathan
- 寄与者
-
- Dutronc, Yves
- 寄与者
メタデータ
- 公開日
- 2021-01-01
- DOI
-
- 10.17632/sd554hbbjb.2
- 10.17632/sd554hbbjb
- 10.17632/sd554hbbjb.1
- 公開者
- Mendeley
- データ作成者 (e-Rad)
-
- Brett King (10341337)
- Justin Ko (10926749)
- Seth Forman (10132532)
- Manabu Ohyama (233210)
- Natasha Mesinkovska (10926752)
- Guanglei Yu (10926755)
- Jill McCollam (10926758)
- Margaret Gamalo (10132544)
- Jonathan Janes (51100)
- Edson-Heredia Emily (10926761)
- Katrin Holzwarth (10132547)
- Yves Dutronc (5370611)
説明
Supplemental material for manuscript published in the Journal for the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2021.05.050